Current Assets Veränderung Datum
AbbVie USD 33.22B 4.37B 2023-09
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Amgen USD 30.33B 18.14B 2023-12
Biogen USD 6.86B 1.59B 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
Heron Therapeutics USD 193.98M 28.7M 2023-09
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
J&J USD 53.7B 6.86B 2023-09
Malin Corporation EUR 32.8M 142.3M 2023-06
Marinus Pharmaceuticals USD 195.04M 431K 2023-09
Merck USD 31.95B 1.98B 2023-09
Minerva Neurosciences USD 48.22M 4M 2023-09
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Otsuka Holdings JPY 1.35T 79.08B 2023-09
Ovoca Bio EUR 4.96M 2.06M 2022-06
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Revance Therapeutics USD 388.52M 9.57M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



ALKERMES Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.